Brisbane Clinical Trials
The COVID-19 Inflammation Study
The purpose of this study is to investigate a potential new treatment for COVID-19.
2 nights
6 visits
Despite major advances made in the development of COVID-19 vaccines and treatments, there are still no effective options for hospitalised patients. It is hoped that this anti-inflammatory study drug would be a potential new treatment for uncontrollable inflammation that is associated with severe COVID-19.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males and females
Age Aged 18 –55 years old, inclusive
Body Weight >50kg
BMI 18 - 30kg/m²
Medical History No significant medical history
Medications Not taking any medication
Smoking History Non-smokers within 3 months of dosing